Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035503 · ClinicalTrials.gov registry record · Phase 2
Multicenter Trial For Patients With Acute Crohn's Disease
A Phase 2 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00035503 is a Phase 2 study that has completed, run by Teva Branded Pharmaceutical Products R&D.
The verdict
NCT00035503, a Phase 2 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
Interventions
- DRUG etiprednol dicloacetate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-01-31 |
| Est. Completion | 2004-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035503
The ClinicalTrials.gov registry entry for NCT00035503 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which etiprednol dicloacetate is the first listed.
NCT00035503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035503 about?
NCT00035503 is a clinical study titled "Multicenter Trial For Patients With Acute Crohn's Disease". The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
What is the current status of trial NCT00035503?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-01-31. Estimated completion is 2004-01-31.
What interventions are being tested in trial NCT00035503?
The interventions under investigation include: etiprednol dicloacetate (DRUG).
Who is sponsoring clinical trial NCT00035503?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.